{"id":"https://openalex.org/W2421665744","doi":"https://doi.org/10.1021/acs.jmedchem.6b00619","title":"Discovery of 3-(3-(4-(1-Aminocyclobutyl)phenyl)-5-phenyl-3 H -imidazo[4,5- b ]pyridin-2-yl)pyridin-2-amine (ARQ 092): An Orally Bioavailable, Selective, and Potent Allosteric AKT Inhibitor","display_name":"Discovery of 3-(3-(4-(1-Aminocyclobutyl)phenyl)-5-phenyl-3 H -imidazo[4,5- b ]pyridin-2-yl)pyridin-2-amine (ARQ 092): An Orally Bioavailable, Selective, and Potent Allosteric AKT Inhibitor","alternate_titles":[],"publication_year":2016,"publication_date":"2016-06-15","ids":{"openalex":"https://openalex.org/W2421665744","doi":"https://doi.org/10.1021/acs.jmedchem.6b00619","mag":"2421665744","pmid":"https://pubmed.ncbi.nlm.nih.gov/27305487"},"language":"en","primary_location":{"id":"doi:10.1021/acs.jmedchem.6b00619","doi":"https://doi.org/10.1021/acs.jmedchem.6b00619","is_oa":false,"landing_page_url":"https://doi.org/10.1021/acs.jmedchem.6b00619","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2421665744"],"child_works_count":1,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5001292543","display_name":"Jean\u2010Marc Lapierre","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210121633","display_name":"Arqule (United States)","ror":"https://ror.org/02nftnt56","country_code":"US","type":"company","lineage":["https://openalex.org/I4210121633"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Jean-Marc Lapierre","raw_affiliation_strings":["ArQule Inc., One Wall Street, Burlington, Massachusetts 01803, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ArQule Inc., One Wall Street, Burlington, Massachusetts 01803, United States","institution_ids":["https://openalex.org/I4210121633"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041253361","display_name":"Sudharshan Eathiraj","orcid":"https://orcid.org/0000-0002-7260-8846","observed_orcids":["https://orcid.org/0000-0002-7260-8846"]},"institutions":[{"id":"https://openalex.org/I4210121633","display_name":"Arqule (United States)","ror":"https://ror.org/02nftnt56","country_code":"US","type":"company","lineage":["https://openalex.org/I4210121633"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sudharshan Eathiraj","raw_affiliation_strings":["ArQule Inc., One Wall Street, Burlington, Massachusetts 01803, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ArQule Inc., One Wall Street, Burlington, Massachusetts 01803, United States","institution_ids":["https://openalex.org/I4210121633"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039580026","display_name":"David Vensel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210121633","display_name":"Arqule (United States)","ror":"https://ror.org/02nftnt56","country_code":"US","type":"company","lineage":["https://openalex.org/I4210121633"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David Vensel","raw_affiliation_strings":["ArQule Inc., One Wall Street, Burlington, Massachusetts 01803, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ArQule Inc., One Wall Street, Burlington, Massachusetts 01803, United States","institution_ids":["https://openalex.org/I4210121633"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100630037","display_name":"Yanbin Liu","orcid":"https://orcid.org/0000-0002-8610-8797","observed_orcids":["https://orcid.org/0000-0002-8610-8797"]},"institutions":[{"id":"https://openalex.org/I4210121633","display_name":"Arqule (United States)","ror":"https://ror.org/02nftnt56","country_code":"US","type":"company","lineage":["https://openalex.org/I4210121633"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yanbin Liu","raw_affiliation_strings":["ArQule Inc., One Wall Street, Burlington, Massachusetts 01803, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ArQule Inc., One Wall Street, Burlington, Massachusetts 01803, United States","institution_ids":["https://openalex.org/I4210121633"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007296799","display_name":"Cathy O. Bull","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210121633","display_name":"Arqule (United States)","ror":"https://ror.org/02nftnt56","country_code":"US","type":"company","lineage":["https://openalex.org/I4210121633"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Cathy O. Bull","raw_affiliation_strings":["ArQule Inc., One Wall Street, Burlington, Massachusetts 01803, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ArQule Inc., One Wall Street, Burlington, Massachusetts 01803, United States","institution_ids":["https://openalex.org/I4210121633"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058333660","display_name":"Susan Cornell-Kennon","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210121633","display_name":"Arqule (United States)","ror":"https://ror.org/02nftnt56","country_code":"US","type":"company","lineage":["https://openalex.org/I4210121633"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Susan Cornell-Kennon","raw_affiliation_strings":["ArQule Inc., One Wall Street, Burlington, Massachusetts 01803, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ArQule Inc., One Wall Street, Burlington, Massachusetts 01803, United States","institution_ids":["https://openalex.org/I4210121633"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103855063","display_name":"Shin Iimura","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210104626","display_name":"Daiichi-Sankyo (Japan)","ror":"https://ror.org/027y26122","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210104626"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Shin Iimura","raw_affiliation_strings":["Daiichi Sankyo Co., Shinagawa R&D Center, 1-2-58, Hiromachi, Shinagawa-ku, Tokyo 140-8710, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Daiichi Sankyo Co., Shinagawa R&D Center, 1-2-58, Hiromachi, Shinagawa-ku, Tokyo 140-8710, Japan","institution_ids":["https://openalex.org/I4210104626"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007460292","display_name":"Eugene W. Kelleher","orcid":"https://orcid.org/0009-0008-9424-6111","observed_orcids":["https://orcid.org/0009-0008-9424-6111"]},"institutions":[{"id":"https://openalex.org/I4210121633","display_name":"Arqule (United States)","ror":"https://ror.org/02nftnt56","country_code":"US","type":"company","lineage":["https://openalex.org/I4210121633"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eugene W. Kelleher","raw_affiliation_strings":["ArQule Inc., One Wall Street, Burlington, Massachusetts 01803, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ArQule Inc., One Wall Street, Burlington, Massachusetts 01803, United States","institution_ids":["https://openalex.org/I4210121633"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052476069","display_name":"Darin E. Kizer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210121633","display_name":"Arqule (United States)","ror":"https://ror.org/02nftnt56","country_code":"US","type":"company","lineage":["https://openalex.org/I4210121633"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Darin E. Kizer","raw_affiliation_strings":["ArQule Inc., One Wall Street, Burlington, Massachusetts 01803, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ArQule Inc., One Wall Street, Burlington, Massachusetts 01803, United States","institution_ids":["https://openalex.org/I4210121633"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083788661","display_name":"Steffi K. Koerner","orcid":"https://orcid.org/0000-0003-2635-6796","observed_orcids":["https://orcid.org/0000-0003-2635-6796"]},"institutions":[{"id":"https://openalex.org/I4210121633","display_name":"Arqule (United States)","ror":"https://ror.org/02nftnt56","country_code":"US","type":"company","lineage":["https://openalex.org/I4210121633"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Steffi Koerner","raw_affiliation_strings":["ArQule Inc., One Wall Street, Burlington, Massachusetts 01803, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ArQule Inc., One Wall Street, Burlington, Massachusetts 01803, United States","institution_ids":["https://openalex.org/I4210121633"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012865694","display_name":"Sapna Makhija","orcid":"https://orcid.org/0009-0001-6862-072X","observed_orcids":["https://orcid.org/0009-0001-6862-072X"]},"institutions":[{"id":"https://openalex.org/I4210121633","display_name":"Arqule (United States)","ror":"https://ror.org/02nftnt56","country_code":"US","type":"company","lineage":["https://openalex.org/I4210121633"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sapna Makhija","raw_affiliation_strings":["ArQule Inc., One Wall Street, Burlington, Massachusetts 01803, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ArQule Inc., One Wall Street, Burlington, Massachusetts 01803, United States","institution_ids":["https://openalex.org/I4210121633"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005997243","display_name":"Akihisa Matsuda","orcid":"https://orcid.org/0000-0002-6468-9375","observed_orcids":["https://orcid.org/0000-0002-6468-9375"]},"institutions":[{"id":"https://openalex.org/I4210104626","display_name":"Daiichi-Sankyo (Japan)","ror":"https://ror.org/027y26122","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210104626"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Akihisa Matsuda","raw_affiliation_strings":["Daiichi Sankyo Co., Shinagawa R&D Center, 1-2-58, Hiromachi, Shinagawa-ku, Tokyo 140-8710, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Daiichi Sankyo Co., Shinagawa R&D Center, 1-2-58, Hiromachi, Shinagawa-ku, Tokyo 140-8710, Japan","institution_ids":["https://openalex.org/I4210104626"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063341697","display_name":"Magdi M. Moussa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210121633","display_name":"Arqule (United States)","ror":"https://ror.org/02nftnt56","country_code":"US","type":"company","lineage":["https://openalex.org/I4210121633"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Magdi Moussa","raw_affiliation_strings":["ArQule Inc., One Wall Street, Burlington, Massachusetts 01803, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ArQule Inc., One Wall Street, Burlington, Massachusetts 01803, United States","institution_ids":["https://openalex.org/I4210121633"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045127959","display_name":"Nivedita D. Namdev","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210121633","display_name":"Arqule (United States)","ror":"https://ror.org/02nftnt56","country_code":"US","type":"company","lineage":["https://openalex.org/I4210121633"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nivedita Namdev","raw_affiliation_strings":["ArQule Inc., One Wall Street, Burlington, Massachusetts 01803, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ArQule Inc., One Wall Street, Burlington, Massachusetts 01803, United States","institution_ids":["https://openalex.org/I4210121633"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007307218","display_name":"Ronald E. Savage","orcid":"https://orcid.org/0000-0001-5374-7106","observed_orcids":["https://orcid.org/0000-0001-5374-7106"]},"institutions":[{"id":"https://openalex.org/I4210121633","display_name":"Arqule (United States)","ror":"https://ror.org/02nftnt56","country_code":"US","type":"company","lineage":["https://openalex.org/I4210121633"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ronald E. Savage","raw_affiliation_strings":["ArQule Inc., One Wall Street, Burlington, Massachusetts 01803, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ArQule Inc., One Wall Street, Burlington, Massachusetts 01803, United States","institution_ids":["https://openalex.org/I4210121633"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049580373","display_name":"Jeff Szwaya","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210121633","display_name":"Arqule (United States)","ror":"https://ror.org/02nftnt56","country_code":"US","type":"company","lineage":["https://openalex.org/I4210121633"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeff Szwaya","raw_affiliation_strings":["ArQule Inc., One Wall Street, Burlington, Massachusetts 01803, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ArQule Inc., One Wall Street, Burlington, Massachusetts 01803, United States","institution_ids":["https://openalex.org/I4210121633"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007582656","display_name":"Erika Volckova","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210121633","display_name":"Arqule (United States)","ror":"https://ror.org/02nftnt56","country_code":"US","type":"company","lineage":["https://openalex.org/I4210121633"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Erika Volckova","raw_affiliation_strings":["ArQule Inc., One Wall Street, Burlington, Massachusetts 01803, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ArQule Inc., One Wall Street, Burlington, Massachusetts 01803, United States","institution_ids":["https://openalex.org/I4210121633"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061753526","display_name":"Neil E. Westlund","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210121633","display_name":"Arqule (United States)","ror":"https://ror.org/02nftnt56","country_code":"US","type":"company","lineage":["https://openalex.org/I4210121633"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Neil Westlund","raw_affiliation_strings":["ArQule Inc., One Wall Street, Burlington, Massachusetts 01803, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ArQule Inc., One Wall Street, Burlington, Massachusetts 01803, United States","institution_ids":["https://openalex.org/I4210121633"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032257574","display_name":"Hui Wu","orcid":"https://orcid.org/0000-0002-3068-3805","observed_orcids":["https://orcid.org/0000-0002-3068-3805"]},"institutions":[{"id":"https://openalex.org/I4210121633","display_name":"Arqule (United States)","ror":"https://ror.org/02nftnt56","country_code":"US","type":"company","lineage":["https://openalex.org/I4210121633"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hui Wu","raw_affiliation_strings":["ArQule Inc., One Wall Street, Burlington, Massachusetts 01803, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ArQule Inc., One Wall Street, Burlington, Massachusetts 01803, United States","institution_ids":["https://openalex.org/I4210121633"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5045588447","display_name":"Brian E. Schwartz","orcid":"https://orcid.org/0000-0003-2632-6351","observed_orcids":["https://orcid.org/0000-0003-2632-6351"]},"institutions":[{"id":"https://openalex.org/I4210121633","display_name":"Arqule (United States)","ror":"https://ror.org/02nftnt56","country_code":"US","type":"company","lineage":["https://openalex.org/I4210121633"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brian Schwartz","raw_affiliation_strings":["ArQule Inc., One Wall Street, Burlington, Massachusetts 01803, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ArQule Inc., One Wall Street, Burlington, Massachusetts 01803, United States","institution_ids":["https://openalex.org/I4210121633"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5001292543"],"corresponding_institution_ids":["https://openalex.org/I4210121633"],"apc_list":{"value":4500,"currency":"USD","value_usd":4500},"apc_paid":null,"fwci":2.6079,"has_fulltext":false,"cited_by_count":136,"citation_normalized_percentile":{"value":0.91211263,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":96,"max":100},"biblio":{"volume":"59","issue":"13","first_page":"6455","last_page":"6469"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10169","display_name":"Protein Kinase Regulation and GTPase Signaling","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/allosteric-akt-inhibitor","display_name":"allosteric AKT inhibitor","score":0.8659999966621399},{"id":"https://openalex.org/keywords/akt1","display_name":"AKT1","score":0.9279999732971191},{"id":"https://openalex.org/keywords/akt2","display_name":"AKT2","score":0.9380000233650208},{"id":"https://openalex.org/keywords/akt3","display_name":"AKT3","score":1.0},{"id":"https://openalex.org/keywords/cyclobutylamine","display_name":"cyclobutylamine","score":0.9679999947547913},{"id":"https://openalex.org/keywords/co-crystal-structure","display_name":"co-crystal structure","score":0.8180000185966492},{"id":"https://openalex.org/keywords/pras40-phosphorylation","display_name":"PRAS40 phosphorylation","score":0.9660000205039978},{"id":"https://openalex.org/keywords/endometrial-adenocarcinoma","display_name":"endometrial adenocarcinoma","score":0.9890000224113464},{"id":"https://openalex.org/keywords/oral-bioavailability","display_name":"oral bioavailability","score":0.746999979019165},{"id":"https://openalex.org/keywords/kinase-inhibitor-discovery","display_name":"kinase inhibitor discovery","score":0.5199999809265137}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.9480587244033813},{"id":"https://openalex.org/C166342909","wikidata":"https://www.wikidata.org/wiki/Q845326","display_name":"Allosteric regulation","level":3,"score":0.6433489918708801},{"id":"https://openalex.org/C2776568683","wikidata":"https://www.wikidata.org/wiki/Q23005640","display_name":"Moiety","level":2,"score":0.5978419780731201},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.5944990515708923},{"id":"https://openalex.org/C154137905","wikidata":"https://www.wikidata.org/wiki/Q17816452","display_name":"AKT1","level":4,"score":0.5592606663703918},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.5208264589309692},{"id":"https://openalex.org/C75217442","wikidata":"https://www.wikidata.org/wiki/Q423650","display_name":"Protein kinase B","level":3,"score":0.514872670173645},{"id":"https://openalex.org/C193042331","wikidata":"https://www.wikidata.org/wiki/Q1772003","display_name":"Structure\u2013activity relationship","level":3,"score":0.49782681465148926},{"id":"https://openalex.org/C11960822","wikidata":"https://www.wikidata.org/wiki/Q242736","display_name":"Phosphorylation","level":2,"score":0.46139073371887207},{"id":"https://openalex.org/C155647269","wikidata":"https://www.wikidata.org/wiki/Q243455","display_name":"Medicinal chemistry","level":1,"score":0.3207513093948364},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.29812386631965637},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.24292981624603271},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.16523367166519165}],"mesh":[{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000494","descriptor_name":"Allosteric Regulation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D000631","descriptor_name":"Aminopyridines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000631","descriptor_name":"Aminopyridines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000631","descriptor_name":"Aminopyridines","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004354","descriptor_name":"Drug Screening Assays, Antitumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007093","descriptor_name":"Imidazoles","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007093","descriptor_name":"Imidazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D007093","descriptor_name":"Imidazoles","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D009374","descriptor_name":"Neoplasms, Experimental","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D009374","descriptor_name":"Neoplasms, Experimental","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015394","descriptor_name":"Molecular Structure","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016889","descriptor_name":"Endometrial Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D016889","descriptor_name":"Endometrial Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D018269","descriptor_name":"Carcinoma, Endometrioid","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D018269","descriptor_name":"Carcinoma, Endometrioid","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D049109","descriptor_name":"Cell Proliferation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D051057","descriptor_name":"Proto-Oncogene Proteins c-akt","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D051057","descriptor_name":"Proto-Oncogene Proteins c-akt","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D051057","descriptor_name":"Proto-Oncogene Proteins c-akt","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055808","descriptor_name":"Drug Discovery","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1021/acs.jmedchem.6b00619","doi":"https://doi.org/10.1021/acs.jmedchem.6b00619","is_oa":false,"landing_page_url":"https://doi.org/10.1021/acs.jmedchem.6b00619","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},{"id":"pmid:27305487","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/27305487","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of medicinal chemistry","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.8371999859809875,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G6490120104","display_name":"Life Science and Biomedical technology Research center at NSLS-II LSBR","funder_award_id":"P41GM111244","funder_id":"https://openalex.org/F4320337354","funder_display_name":"National Institute of General Medical Sciences"}],"funders":[{"id":"https://openalex.org/F4320337354","display_name":"National Institute of General Medical Sciences","ror":"https://ror.org/04q48ey07"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":20,"referenced_works":["https://openalex.org/W1501280762","https://openalex.org/W1876597264","https://openalex.org/W1964407556","https://openalex.org/W1966133006","https://openalex.org/W1990332775","https://openalex.org/W2009364489","https://openalex.org/W2017181626","https://openalex.org/W2043865307","https://openalex.org/W2047132220","https://openalex.org/W2065547075","https://openalex.org/W2065852814","https://openalex.org/W2079029484","https://openalex.org/W2079521830","https://openalex.org/W2125314903","https://openalex.org/W2129242642","https://openalex.org/W2141125222","https://openalex.org/W2162103271","https://openalex.org/W2204493619","https://openalex.org/W2290057196","https://openalex.org/W4294214970"],"related_works":["https://openalex.org/W1994840494","https://openalex.org/W2012310946","https://openalex.org/W1976424674","https://openalex.org/W2045211625","https://openalex.org/W2079521830","https://openalex.org/W2087017252","https://openalex.org/W2176372170","https://openalex.org/W1995727862","https://openalex.org/W1969218954","https://openalex.org/W2137807443"],"abstract_inverted_index":{"The":[0,29],"work":[1],"in":[2,101],"this":[3,46],"paper":[4],"describes":[5],"the":[6,9,23,40,50,53,77,80,93],"optimization":[7],"of":[8,18,25,32,43,45,52,73,79,92,107],"3-(3-phenyl-3H-imidazo[4,5-b]pyridin-2-yl)pyridin-2-amine":[10],"chemical":[11,47],"series":[12],"as":[13,67,69,88],"potent,":[14],"selective":[15],"allosteric":[16,41],"inhibitors":[17],"AKT":[19,74],"kinases,":[20],"leading":[21],"to":[22,36],"discovery":[24],"ARQ":[26],"092":[27],"(21a).":[28],"cocrystal":[30],"structure":[31],"compound":[33],"21a":[34,57,85],"bound":[35],"full-length":[37],"AKT1":[38],"confirmed":[39],"mode":[42],"inhibition":[44,72],"class":[48],"and":[49,65,76,97],"role":[51],"cyclobutylamine":[54],"moiety.":[55],"Compound":[56,84],"demonstrated":[58],"high":[59],"enzymatic":[60],"potency":[61],"against":[62],"AKT1,":[63],"AKT2,":[64],"AKT3,":[66],"well":[68],"potent":[70,90],"cellular":[71],"activation":[75],"phosphorylation":[78],"downstream":[81],"target":[82],"PRAS40.":[83],"also":[86],"served":[87],"a":[89,102],"inhibitor":[91],"AKT1-E17K":[94],"mutant":[95],"protein":[96],"inhibited":[98],"tumor":[99],"growth":[100],"human":[103],"xenograft":[104],"mouse":[105],"model":[106],"endometrial":[108],"adenocarcinoma.":[109]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2421665744","counts_by_year":[{"year":2026,"cited_by_count":22},{"year":2025,"cited_by_count":13},{"year":2024,"cited_by_count":20},{"year":2023,"cited_by_count":14},{"year":2022,"cited_by_count":19},{"year":2021,"cited_by_count":11},{"year":2020,"cited_by_count":8},{"year":2019,"cited_by_count":11},{"year":2018,"cited_by_count":9},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":5}],"updated_date":"2026-11-19T14:11:59.513116","created_date":"2016-06-24T00:00:00"}
